logo

Latest Financial Updates

Read latest financial news update from our blog

For large-cap IT investors, the wait for redemption can be a long one
For large-cap IT investors, the wait for redemption can be a long one

—Lemony Snicket 9 March 2006. Arsenal Stadium, Highbury, north London. The home crowd e...

Admin | Finance | 1 month ago

The World’s Best Sour Beer—According To The European Beer Star
The World’s Best Sour Beer—According To The European Beer Star

Sour beers may not be as popular as other beer styles but they are influential among brewe...

Admin | Finance | 1 month ago

Bain sees Saudi construction industry poised for 4.5% expansion
Bain sees Saudi construction industry poised for 4.5% expansion

Bain & Company forecasts a 3.5% to 4.5% compound annual growth rate (CAGR) for the Saudi c...

Admin | Finance | 1 month ago

ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of FTAI Aviation By Investing.com
ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of FTAI Aviation By Investing.com

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investor...

Admin | Finance | 1 month ago

ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Regeneron Pharmaceuticals By Investing.com
ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Regeneron Pharmaceuticals By Investing.com

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investor...

Admin | Finance | 1 month ago

Nomu: Qomel hits highest price since debut
Nomu: Qomel hits highest price since debut

Agree Argaam Investment Company has updated the Privacy Policy of its services and digita...

Admin | Finance | 1 month ago

Forget The Mag-7: 2 Of My Favorite Dividend Winners Built To Thrive
Forget The Mag-7: 2 Of My Favorite Dividend Winners Built To Thrive

Join iREIT on Alpha today to get the most in-depth research that includes REITs, mREITs, P...

Admin | Finance | 1 month ago

AbbVie: Q4 2024 Earnings Preview And Update On Emraclidine (NYSE:ABBV)
AbbVie: Q4 2024 Earnings Preview And Update On Emraclidine (NYSE:ABBV)

I publish my best ideas and top coverage on the Growth Stock Forum . If you're interested...

Admin | Finance | 1 month ago

Join Our Newsletter

join our newsletter to receive update from us